Tags SARS-Cov-2 vaccine

Kaneka Eurogentec will manufacture INOVIO’s DNA vaccine candidate against COVID-19

INOVIO has assembled a global coalition of collaborators, partners and funders to rapidly advance the development of INO-4800, a DNA vaccine against the novel coronavirus SARS-CoV-2. INOVIO’s President & CEO, Dr. J. Joseph Kim, said, “Our partnership with Kaneka Eurogentec, one of the world’s lar...

Covid-19 vaccines

@**************************************************************** HeaderWhite *****************************************************************************@ : 261–279 – DOI : 10.1038/nrd.2017.243. } @********************************************************************************* End OneColumn 0...